⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

January 1, 2008Clinical Chemistry and Laboratory Medicine (CCLM)

Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease

Mehdi Rasouli Asadollah Mohseni Kiasari

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

The results indicate that serum Lp(a) does interact multiplicatively with diabetes, apoB and cholesterol. The simultaneous assessment of Lp(a) and interactive risk factors enhances the discriminating value for CAD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rasouli et al. (2008) studied this question.

synapsesocial.com/papers/69effb624f6a06657c21e403 https://doi.org/10.1515/cclm.2008.137

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Elevated Plasma Lipoprotein(a) Is Associated With Coronary Artery Disease in Patients With Chronic Stable Angina Pectoris 11Dr. Cox is supported by a Fellowship Grant from the British Heart Foundation, London.Cohort Study · 1998 · 58 citations
2Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart diseaseCase-Control Study · 2003 · 27 citations
3A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project ParticipantsCohort Study · 1997 · 195 citations
4Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaOriginal Research · 1990 · 585 citations
5Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial Hypercholesterolemiacohort · 2005 · 72 citations
6Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group.Original Research · 1992 · 72 citations
7Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)Blinded Clinical Trial · 1995 · 297 citations
8Lipoprotein (a) and coronary heart diseaseOriginal Research · 1995 · 141 citations
9Plasma free light chains across chronic kidney disease stages: real-world patterns of kappa, lambda, and κ/λ ratioClinical Chemistry and Laboratory Medicine (CCLM) · 2026
10PCR hyper-automation: an example of spinal muscular atrophy and severe combined immunodeficiency screeningClinical Chemistry and Laboratory Medicine (CCLM) · 2026

More from Clinical Chemistry and Laboratory Medicine (CCLM)

More from Mazandaran University of Medical Sciences